Your session is about to expire
← Back to Search
TB006 for Alzheimer's Disease
Study Summary
This trial is for people with Alzheimer's who have completed another study, or who weren't able to be in the other study. It will last 113 weeks and researchers will be looking at how safe and well tolerated the study drug is, as well as how it affects the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 1 & 2 trial • 154 Patients • NCT05074498Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had major surgery, significant blood loss, or used alcohol/substances recently.I cannot become pregnant.I have a condition that could lead to memory loss.My condition is a type of dementia that is not Alzheimer's disease.I can read, write, and communicate effectively.I cannot have an MRI due to certain health issues.You scored 24 or lower on the memory and thinking test.
- Group 1: TB006 4000 mg
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What perils does TB006 pose to humans?
"Due to the experimental nature of TB006, our team at Power rated its safety a 2 as there is only evidence supporting its safety and not efficacy."
Is it still possible to join this trial and participate?
"According to clinicaltrials.gov, this medical trial has ended its recruitment process as of October 19th 2022. Initially posted on September 14th 2022, the study is no longer seeking new candidates; however, there are an abundance of other trials that remain open for enrollment at present."
In what locations is the trial being conducted?
"At present, 10 diverse sites across the country are running this medical trial. These locations include Maitland, West Palm Beach and Lady Lake as well as other nearby cities. To limit travel demands when enrolling, it is wise to select a location closest to you."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger